It is important to note, however, that while oral candidiasis was observed, the causative link to psoriasis treatment cannot be definitively established, aligning with previous reports that some adverse events during long-term IL-17 inhibitor therapy may not be directly attributable to the drug itself. The gene discussed is IL17A; the disease is oral candidiasis.